Trial Profile
Real-world outcomes of luseogliflozin in elderly patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jan 2018
Price :
$35
*
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 11 Jan 2018 New trial record
- 08 Dec 2017 Results presented at the 2017 Congress of the International Diabetes Federation